Category : Search result: Bryan Johnson biotech CEO


Tom Brady's Secret Dog Clone Revealed in Ethics Storm

Exclusive investigation uncovers how American football icon Tom Brady paid £40,000 to clone his cherished dog through controversial biotech firm Viagen, raising ethical questions about pet cloning technology.

Kimberly-Clark in Merger Talks with Kenvue

In a seismic shift for consumer healthcare, household goods titan Kimberly-Clark is reportedly in advanced discussions to acquire Kenvue, the company behind Tylenol and Band-Aid, in a deal that could reshape the global market.

Biohacker's £1.7M morning routine to reverse ageing

Discover how tech millionaire Bryan Johnson spends over £1.7 million annually on his bizarre morning routine designed to reverse ageing, featuring green juice, dozens of supplements and electromagnetic penis therapy.

Texas Lawsuit Demands Tylenol Pregnancy Warning

A landmark legal case in Texas could force Johnson & Johnson to add pregnancy warnings to Tylenol packaging, following claims linking the common painkiller to autism and ADHD in children.

Bryan Johnson eliminates microplastics from body

Silicon Valley biohacker Bryan Johnson reveals groundbreaking results after intensive detox programme eliminated microplastics from his system, challenging conventional health wisdom.

Dakota Johnson Addresses 'Nepo Baby' Label Honestly

Hollywood star Dakota Johnson opens up about her famous parents Melanie Griffith and Don Johnson, confronting the 'nepo baby' conversation with refreshing honesty about privilege and pressure in Tinseltown.

J&J Pays $700M in Talc Cancer Scandal Settlement

Pharmaceutical giant Johnson & Johnson agrees to pay $700 million settlement amid allegations their talcum powder contained asbestos and caused ovarian cancer in thousands of women.

Woman Sues Johnson & Johnson Over Talc Cancer Claims

A British woman with terminal cancer is taking legal action against Johnson & Johnson, claiming their talc-based products caused her illness in a case that could have significant implications for consumer safety.

Johnson & Johnson Faces UK Lawsuit Over Talc Cancer Claims

Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.

J&J Faces New Asbestos Claims in Talc Powder

New court documents reveal shocking internal communications about asbestos contamination in Johnson & Johnson's iconic baby powder, potentially affecting millions of UK consumers.

LA Metro CEO's Secret Settlement Package Revealed

Exclusive investigation reveals how Los Angeles Metro CEO Fesia Davenport received a substantial settlement package to quietly exit her role, raising serious questions about transparency and accountability in public transportation leadership.

LendingTree CEO Doug Lebda Dies at 56

Financial technology pioneer and LendingTree founder Doug Lebda has died unexpectedly at 56, leaving the business world mourning the loss of a visionary leader who revolutionised online lending.

Biohacker's £1.7m diet to cheat death revealed

Tech millionaire Bryan Johnson reveals his extreme anti-ageing protocol involving precise meals, 100+ daily supplements and rigorous monitoring in his quest to reverse biological ageing.

Bryan Johnson rejects Ozempic for extreme biohacking

Tech entrepreneur Bryan Johnson discloses why he refuses weight-loss injections like Ozempic and Mounjaro, opting instead for his extreme £1.8 million annual biohacking regimen to achieve 5% body fat.

Biotech tycoon guilty in murder-for-hire plot

Serhat Gumrukcu, once celebrated for COVID-19 treatment research, faces life imprisonment after being found guilty of orchestrating the murder of Vermont businessman Gregory Davis in a shocking conspiracy.

Trump's Tylenol Gaffe Sends Wall Street into Frenzy

Former President Donald Trump's confusion between Tylenol and hydroxychloroquine during the presidential debate triggers a sharp sell-off in pharmaceutical stocks, with Kenvue shares taking a significant hit.

Page 1 of 4